Mindray Medical Beats Estimates with Strong Q2 Report
Mindray Medical, the Shenzhen maker of medical devices, reported Q2 revenues climbed 23% to $267.8 million, handily beating expectations of $258.7 million. Per Share earnings were $.50, well ahead of the $.45 predicted by analysts. Because the report was a pleasant surprise, Mindray’s stock price rose almost 12% in today’s trading, moving up $3.61 to $34.96. More details.... Stock Symbol: (NYSE: MR) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here